Cargando…
Superselective embolization for high-flow priapism refractory to medical and surgical treatments
BACKGROUND: This study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments. METHODS: From August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325169/ https://www.ncbi.nlm.nih.gov/pubmed/32605599 http://dx.doi.org/10.1186/s12894-020-00653-y |
_version_ | 1783552100857282560 |
---|---|
author | Bi, Yonghua Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang |
author_facet | Bi, Yonghua Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang |
author_sort | Bi, Yonghua |
collection | PubMed |
description | BACKGROUND: This study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments. METHODS: From August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and their charts were retrospective reviewed. Clinical evaluation, color Doppler ultrasonography, arteriography and selective embolization were performed. Follow up was performed in all patients. Fourteen men (18–63 years old) were enrolled, with priapism duration of 14 h to 28 days. Internal pudendal arteries or glutaea inferior arteriae were successfully embolized with gelatin sponge particles, polyvinyl alcohol particles or microcoils. RESULTS: Pseudoaneurysm in right femoral artery was found in one case after intervention. The follow-up 1 week later showed that 13 patients were in good condition, the priapism diminished 1–7 days (mean 3.2 ± 0.5 days) after intervention, and 1 patient received second intervention. Mean follow-up was (range 10.8–69.6) months. One patient had recurrent priapism months after embolization and had his penis surgically removed for severe necrosis. CONCLUSIONS: Superselective embolization is safe and effective in high-flow priapism refractory local treatments, with a good long-term prognosis. |
format | Online Article Text |
id | pubmed-7325169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73251692020-06-30 Superselective embolization for high-flow priapism refractory to medical and surgical treatments Bi, Yonghua Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang BMC Urol Research Article BACKGROUND: This study aimed to report long-term outcome of superselective embolization in patients with high-flow priapism refractory to medical and surgical treatments. METHODS: From August 2011 until July 2016, 14 patients with high-flow priapism refractory to local treatments were treated and their charts were retrospective reviewed. Clinical evaluation, color Doppler ultrasonography, arteriography and selective embolization were performed. Follow up was performed in all patients. Fourteen men (18–63 years old) were enrolled, with priapism duration of 14 h to 28 days. Internal pudendal arteries or glutaea inferior arteriae were successfully embolized with gelatin sponge particles, polyvinyl alcohol particles or microcoils. RESULTS: Pseudoaneurysm in right femoral artery was found in one case after intervention. The follow-up 1 week later showed that 13 patients were in good condition, the priapism diminished 1–7 days (mean 3.2 ± 0.5 days) after intervention, and 1 patient received second intervention. Mean follow-up was (range 10.8–69.6) months. One patient had recurrent priapism months after embolization and had his penis surgically removed for severe necrosis. CONCLUSIONS: Superselective embolization is safe and effective in high-flow priapism refractory local treatments, with a good long-term prognosis. BioMed Central 2020-06-30 /pmc/articles/PMC7325169/ /pubmed/32605599 http://dx.doi.org/10.1186/s12894-020-00653-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Bi, Yonghua Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang Superselective embolization for high-flow priapism refractory to medical and surgical treatments |
title | Superselective embolization for high-flow priapism refractory to medical and surgical treatments |
title_full | Superselective embolization for high-flow priapism refractory to medical and surgical treatments |
title_fullStr | Superselective embolization for high-flow priapism refractory to medical and surgical treatments |
title_full_unstemmed | Superselective embolization for high-flow priapism refractory to medical and surgical treatments |
title_short | Superselective embolization for high-flow priapism refractory to medical and surgical treatments |
title_sort | superselective embolization for high-flow priapism refractory to medical and surgical treatments |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325169/ https://www.ncbi.nlm.nih.gov/pubmed/32605599 http://dx.doi.org/10.1186/s12894-020-00653-y |
work_keys_str_mv | AT biyonghua superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments AT yimengfei superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments AT yuzepeng superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments AT hanxinwei superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments AT renjianzhuang superselectiveembolizationforhighflowpriapismrefractorytomedicalandsurgicaltreatments |